Tag: Therapeutics
GSK acquires oligonucleotide drug startup Elsie
This follows a successful research collaboration with Elsie, announced in July 2023, in which GSK was able to explore and validate the technology
Biocon Biologics obtains US-FDA approval for biosimilar Aflibercept for Yesafili
A significant milestone for the company marking its entry into ophthalmology, a new therapeutic area in the United States
Lupin Digital Health introduces Digital Therapeutics Certificate for Cardiologists
This collaboration is crucial in ensuring top-notch care and enhancing outcomes, all from the convenience of patients' homes
CSIR-CDRI collaborates with Bengaluru based startup to develop novel therapeutics for...
The collaboration will entail the use of advanced artificial intelligence and computational tools developed at Sravathi AI to design novel chemical entities (NCEs) with anti-cancer properties
Ultragenyx’s UX053 Phase I/II study termination a minor setback for mRNA...
The study was terminated due to reasons unrelated to safety concerns, although the specific rationale has not been disclosed by the biopharmaceutical company
UW-Madison Global Health Institute partners Ella Foundation to establish first-ever ‘UW-Madison...
Partnership expands the Wisconsin Idea by providing interdisciplinary collaborations with UW-Madison, the Ella Foundation, and Bharat Biotech
US subsidiary of Zydus Lifesciences buys BridgeBio Pharma’s NULIBRY
NULIBRY is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
A painkiller that doesn’t hurt!
An international research team has examined the therapeutic and adverse effects of a newly synthesized potentially safer compound with anti-inflammatory and analgesic properties, opening doors to novel drugs for patients in need
Indian scientists develop new compound to treat Autism
Researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have developed a compound that has demonstrated a potential to restore neuronal function, learning and memory, and reduce epileptic seizures in a mouse model.................
Aragen partners Skyhawk Therapeutics to develop novel molecules that correct RNA...
Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions.....................